University-Based Science and Biotechnology Products
Data up to Jan 2025
Total Citations Per Year
Abstract
References (18)
Can Patents Deter Innovation? The Anticommons in Biomedical Research
1998 • 2,603 citations
Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not)
2000 • 1,678 citations
Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting
2000 • 1,102 citations
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.
1992 • 838 citations
Withholding Research Results in Academic Life Science
1997 • 590 citations
A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.
1991 • 571 citations
Powerful medicines: the benefits, risks, and costs of prescription drugs
2005 • 199 citations
No-Fault Compensation for Medical Injuries
2001 • 170 citations
Medical Innovation and Institutional Interdependence
2002 • 130 citations
Diagnostic testing fails the test
2002 • 123 citations
Genes and patent policy: rethinking intellectual property rights
2002 • 85 citations
The Economics of Human Gene Patents
2002 • 75 citations
Induction of cyclo‐oxygenase by interleukin‐1 in rheumatoid synovial cells
1987 • 59 citations
The Illusion of Efficiency in Workers' Compensation "Reform"
1998 • 37 citations
Biobusiness on campus: commercialization of university-developed biomedical technologies.
1997 • 17 citations
French researchers take a stand against cancer gene patent
2001 • 16 citations
Vital Assets: Federal Investment in Research and Development at the Nation's Universities and Colleges
2004 • 15 citations
Medical innovation and institutional interdependence. Rethinking university-industry connections.Gelijns AC, ∗∗College of Physicians and Surgeons and School of Public Health, Columbia University, 600 W 168th St., Seventh Floor, New York, NY 10032. E-mail: [email protected] Thier SO. JAMA 2002;287:72–77.
2002 • 12 citations